| scholarly article | Q13442814 |
| P50 | author | Collynn F Woeller | Q90179006 |
| P2093 | author name string | Richard P Phipps | |
| Steven E Feldon | |||
| Christine L Hammond | |||
| Elisa Roztocil | |||
| P2860 | cites work | 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway: role of the transcription activaton and DNA binding of AhR | Q23919662 |
| Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge | Q26782820 | ||
| Recent developments in myofibroblast biology: paradigms for connective tissue remodeling | Q26863751 | ||
| 25 Years of Proton Pump Inhibitors: A Comprehensive Review | Q28070003 | ||
| Nrf2-inducing anti-oxidation stress response in the rat liver--new beneficial effect of lansoprazole | Q28538990 | ||
| Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis | Q28660307 | ||
| Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). | Q30422043 | ||
| What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease | Q30429628 | ||
| Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines | Q33700433 | ||
| A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease. | Q34025656 | ||
| The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis | Q34485137 | ||
| New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor. | Q55024151 | ||
| A new highly thyrotropin receptor-selective small molecule antagonist with potential for the treatment of Graves' orbitopathy | Q57800155 | ||
| Proton pump inhibitors: Review of reported risks and controversies | Q60128927 | ||
| Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro | Q79843215 | ||
| Interaction between the aryl hydrocarbon receptor and transforming growth factor-beta signaling pathways: evidence of an asymmetrical relationship in rat granulosa cells | Q81955419 | ||
| Teprotumumab for Thyroid-Associated Ophthalmopathy. | Q34556184 | ||
| Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications | Q34561866 | ||
| The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation | Q34805707 | ||
| Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation | Q35125945 | ||
| Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes | Q35265520 | ||
| Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis | Q35908085 | ||
| Ah receptor signals cross-talk with multiple developmental pathways | Q35997552 | ||
| Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells | Q36335539 | ||
| The pathophysiology of thyroid eye disease: implications for immunotherapy. | Q36439938 | ||
| Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling | Q37277392 | ||
| Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways | Q37291837 | ||
| Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor | Q37514105 | ||
| Graves' orbitopathy: imperfect treatments for a rare disease | Q37582446 | ||
| Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model. | Q37607150 | ||
| Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. | Q38355897 | ||
| Myofibroblasts | Q38550797 | ||
| Current Insights into the Pathogenesis of Graves' Ophthalmopathy | Q38585018 | ||
| Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy | Q38671312 | ||
| Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways | Q38740654 | ||
| The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease | Q38795531 | ||
| The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review | Q38849908 | ||
| Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways | Q39008804 | ||
| Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors | Q40205035 | ||
| Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). | Q42501461 | ||
| Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245 | Q43221245 | ||
| The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value | Q47281033 | ||
| Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers | Q47383813 | ||
| Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. | Q47803690 | ||
| Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy | Q48147801 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | e0222779 | |
| P577 | publication date | 2019-09-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor | |
| P478 | volume | 14 |
Search more.